1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPositive Action towards HIV Community is sponsored by ViiV Healthcare. Engages with organizations at national, regional, and local levels to develop and fund innovative community-based programs addressing HIV disparities.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Positive Action HIV Community Grants | ViiV Healthcare US This link will take you to a non-ViiV Healthcare website. ViiV Healthcare does not recommend, endorse or accept liability for sites controlled by third-parties. We are ViiV Healthcare: 100% dedicated to HIV medicines and research and completely focused on people affected by HIV and AIDS.
Our commitment to global health Corporate ethics and compliance Learn about our HIV medicines We are dedicated to treat, prevent and hopefully one day, cure HIV. Find out about our research initiatives in the fight against HIV. Learn about our HIV research Implementation science research Our stories of science and innovation We work actively with communities affected by HIV and AIDS around the world.
Read about our community engagement initiatives. Learn about our community engagement Positive Action AMP Grant We are the only pharmaceutical company solely focused on curing HIV and AIDS, but of course, none of what we do can be achieved alone – we believe in the power of partnership. We are ViiV Healthcare: 100% dedicated to HIV medicines and research and completely focused on people affected by HIV and AIDS.
Our commitment to global health Corporate ethics and compliance Learn about our HIV medicines We are dedicated to treat, prevent and hopefully one day, cure HIV. Find out about our research initiatives in the fight against HIV. Learn about our HIV research Implementation science research Our stories of science and innovation We work actively with communities affected by HIV and AIDS around the world.
Read about our community engagement initiatives. Learn about our community engagement Positive Action AMP Grant We are the only pharmaceutical company solely focused on curing HIV and AIDS, but of course, none of what we do can be achieved alone – we believe in the power of partnership.
We are committed to supporting community organizations in the U.S. that work to address disparities and close gaps in care for those most affected by HIV. Together, we aim to provide organizations with grants to reach those not currently benefitting from existing HIV support services or programs.
Positive Action Community Grants Through Positive Action Community Grants (PACG), ViiV Healthcare supports community-led efforts to increase engagement in prevention and care, address stigma, and build trust in HIV care among communities most disproportionately impacted by HIV. Organizations applying to PACG may request funding for general operating support, or project support.
To ensure ViiV Healthcare is focused on the sponsorship opportunities that best support our mission, we proactively identify the events that we will sponsor. This means ViiV is unable to accept unsolicited requests for sponsorship support. We also do not accept applications for sponsorships through grants.
If ViiV has interest in sponsoring an event, we will reach out to the appropriate event organizer. This process allows us to streamline the process for ViiV sponsored events and most efficiently support community. ViiV remains committed and engaged in supporting community activities that work to address disparities and close gaps in care for those most affected by HIV.
For any questions, please contact viiv@tccgrp. com . Positive Action for Women Through our Positive Action for Women program, we are committed to breaking down isolation and stigma to improve access to networks of care for women of color living with and affect by HIV.
Positive Action Southern Initiative Through our Positive Action Southern Initiative program, we are committed to expanding and enhancing community-based linkage to care services and adherence to treatment for people living with and affected by HIV in the Southern US.
Through the accelerate Initiative, ViiV Healthcare supports place-based, community-driven activities that strengthen the health and well-being of Black men who have sex with men. Tel: +1 877 ViiVUSA (+1 877 844 8872) To report a suspected side effect, please use our online reporting form . You are about to leave a ViiV Healthcare website.
By clicking this link, you will be taken to a website that is independent from ViiV Healthcare. The site you are linking to is not controlled or endorsed by ViiV Healthcare and ViiV Healthcare is not responsible for the content provided on that site.
This is an archived press release which may not reflect current medical knowledge and should not be used as a source of information on the present label, safety data or efficacy data for ViiV Healthcare products and/or their uses. Please refer to your nationally approved label or summary of product characteristics for up-to-date product information.
According to the current listing, eligibility includes: Nonprofits, community-based organizations, and local groups in the U. S. Confirm the full requirements in the official notice before applying.
Positive Action towards HIV Community is funded by ViiV Healthcare. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Supporting industry in the switch to sustainable and circular bio-based products and processes is sponsored by European Commission — Horizon Europe. Expected Outcome: Successful proposals will contribute to updated EU Bioeconomy Strategy, the Clean Industrial Deal, the European Chemical Industry Action Plan and the upcoming Circular Economy Act. Projects results are expected to contribute to the following expected outcomes: Identification of technical, market and regulatory barriers and possible solutions for industry to ‘switch to bio-based’. Contribution to filling the gap between bio-based sectors and the broader industrial landscape. Scope: While the share of bio-based products and processes in traditionally non-bio-based markets has been growing substantially in recent years, many non-bio-based, partially bio-based and more traditional bio-based industries (such as food industry) still perceive market and regulatory situations as uncertain and may therefore be reluctant to invest in new bio-based value chains. These uncertainties may relate to cost competition versus fossil-based counterparts, first-mover hesitation, lack of investment attractiveness, regulatory issues, uncertainties in feedstock quality and availability, lack of knowledge, shortage of relevant skills, etc.. Notwithstanding these challenges, industries recognise the opportunity of ‘switching to bio-based’ to improve their sustainability profile and meet consumers’ expectations. Proposals under this topic should: Perform a consultation among non-bio-based and partially bio-based industries to identify barriers preventing them to adopt/diversify bio-based feedstock and processes in their operations. Include at least 3 industrial sectors that are critical for the green transition. Make sure to include a representative sample of industries with different size (including SMEs and startups) and position in the value chain and covering regions with different specialisations. Analyse the outcomes from the consultation to identify barriers to bio-based transition and propose possible solutions. Validate the results with end users/consumers to include their perspectives. Identify case studies and success stories showcasing best practises leading to adoption of bio-based solutions and assess their replication potential in the non-bio-based and partially bio-based sectors in scope. Create a forum bringing together bio-based industries, feedstock providers, non-bio-based and partially bio-based industries, investors, policymakers, demand-side actors (e.g., large retailers, end-users, public procurers, etc.) as well as existing or upcoming stakeholders’ groups under the CBE JU, to facilitate the dialogue among the stakeholders and identify possible pathways for cooperation. Develop and publish sectoral and cross-sectoral roadmaps towards the ‘switch to bio-based’ for the (at least 3) targeted non-bio-based or partially bio-based industrial sectors, also identifying de-risking opportunities. In addition to the specific requirements applicable for the type of action, as described in section 2.2.3.1 of the CBE JU Annual Work Programme 2026 [1] , proposals under this topic should: : Ensure complementarities with past and ongoing R&I projects addressing similar challenges, including projects funded under Horizon 2020/Horizon Europe, BBI JU/CBE JU projects as well as COST actions. [1] https://www.cbe.europa.eu/reference-documents Programme areas: Global Challenges and European Industrial Competitiveness, Food, Bioeconomy Natural Resources, Agriculture and Environment, Bio-based Innovation Systems in the EU Bioeconomy, Horizon Europe (HORIZON) Keywords: Competitiveness, innovation, research and development, Innovation policy, Market analysis, Market development, barriers, bio-based industrial transformation, bio-based market, green transition, investment, knowledge, market development, market strategy, skills, stakeholder dialogue
SSbD bio-based alternatives for fertilising and/or crop protection products is sponsored by European Commission — Horizon Europe. Expected Outcome: Successful proposals will contribute to the updated EU Bioeconomy Strategy, Farm to Fork Strategy, the Horizon Europe Mission ‘A Soil Deal for Europe’, in particular the objectives: ‘Reduce soil pollution and enhance restoration’, the European Chemical Industry Action Plan as well as the Clean Industrial Deal. Projects results are expected to contribute to the following expected outcomes: Full industrial scale biorefinery and related value chain(s) for the sustainable production of bio-based fertilisers and/or crop protection solutions. Increased availability of cost-competitive and SSbD bio-based alternatives for fertilising and/or crop protection products with suitable agronomic efficacy. Reduced reliance on synthetic/mineral agricultural chemical products. Increased EU strategic autonomy, resilience and competitiveness through a robust cooperation among bio-based industries and farmers. Increased soil health, including minimising accumulation of microplastics and pollutants in soil and water, with positive effects on quality, security and resilience of food production in agriculture. Scope: FAO estimates that up to 40% of food crops are lost due to plant pests and diseases globally every year. [1] Chemical synthetic products are conventionally used to protect crops and other plants from pests and diseases. In parallel, the EU is largely dependent on imports of both mineral and chemical fertilisers to grow crops. In both cases, over-use of synthetic/mineral products also poses concern for soil health and food quality. Moreover, the unequal distribution and depletion of non-renewable sources risks disrupting supply chains, particularly during energy crises. SSbD bio-based fertilising and crop protection products can offer more resilient and sustainable solutions creating an added-value partnership between agriculture and industry both upstream (for feedstock supply) and downstream (for the use of sustainable and efficient bio-based products). However, when scaling-up, challenges need to be solved in terms of process efficiency and robustness against feedstock variability, formulations stability and efficacy on the field (also in consideration of climate change effects and different soil conditions), and cost competitiveness. Proposals under this topic should: Demonstrate (at TRL 8) the efficient industrial production of SSbD bio-based solutions as alternatives to current fertilising and/or crop protection products. Bioactive molecules and/or biotechnology solutions for bio-fertilisers, bio-stimulants and/or pest/disease control (e.g., bioherbicides, biopesticides, bioinsecticides), or a combination thereof, are in scope. Products in scope can be applicable at any crop(s) cycle stage. Validate (at TRL 6 and above) at scale the produced bio-alternatives into the formulation of end-product(s) and test their agronomic efficiency, safety and sustainability to prove the achievement of similar or improved properties compared to defined benchmarks available in the market (synthetic and/or mineral). In case of bio-based fertilisers, put in place a solid production validation procedure to ensure reduced nutrient variability of the N/P/K content in end-products. Test the developed product(s) with primary producers on the field (demo farms) for selected crops and monitor their effects on soil health and quality, as well as on water. Cover different climatic and soil conditions, taking into account different farming systems, including organic agriculture. If controlled release mechanisms are employed, the proposed innovations should avoid microplastics accumulation in soil. In addition to the specific requirements applicable for the type of action, as described in section 2.2.3.1 of the CBE JU Annual Work Programme 2026 [2] , proposals under this topic should: As part of the multi-actor approach (MAA), ensure adequate involvement of all key actors in the value chains relevant for this topic and across the sustainable cir Programme areas: Global Challenges and European Industrial Competitiveness, Food, Bioeconomy Natural Resources, Agriculture and Environment, Bio-based Innovation Systems in the EU Bioeconomy, Horizon Europe (HORIZON) Keywords: Agricultural biotechnology, Agriculture related to crop production, soil biology and cultivation, applied plant biology, Agronomy, Fertilisation, agricultural biotechnology, bio-based crop protection solutions, bio-based fertilisers, bioactive molecules, biorefineries, farming systems, safe and sustainable by design, STEP-Biotech
USDA's FY2026 GusNIP Produce Prescription Program will make roughly 12 awards of up to $500,000 over three years — with no matching requirement — to nonprofits and government agencies that partner with healthcare providers to prescribe fresh fruits and vegetables. Here is who is eligible, why the mandatory clinical partner is the whole game, how the evidence base got strong enough to matter, and how to build a July 16 application.
Read articleDespite NIH budget pressure, hundreds of millions in AI healthcare research grants remain active in 2026. Full breakdown of Bridge2AI, AHRQ patient safety, NSF/NIH Smart Health, BARDA, Gates Foundation, and Google.org — with eligibility, amounts, and current deadlines.
Read articleThe Rural Health Care Program's Third Further Notice hit the Federal Register on August 31, 2026. It proposes killing cost studies, publishing an eligible services list, setting application processing deadlines, and eliminating the Healthcare Connect Fund annual report. What it conspicuously does not propose is any change to the $744.2 million cap that the whole proceeding says is under strain.
Read article